<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The aim of the study was to assess the possible correlation between <z:chebi fb="2" ids="33567">catecholamine</z:chebi> and <z:chebi fb="1" ids="17650">cortisol</z:chebi> levels and changes in cerebral hemodynamics in patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0038436" disease_type="Mental or Behavioral Dysfunction" abbrv="PTSD">posttraumatic stress disorder (PTSD)</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The study included 50 patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTSD</z:e> first ever hospitalized for psychiatric treatment and 50 healthy control subjects </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> study subjects were aged 30-50 </plain></SENT>
<SENT sid="3" pm="."><plain>In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTSD</z:e> patients, 24-h urine levels of the <z:chebi fb="2" ids="28918">epinephrine</z:chebi> and <z:chebi fb="1" ids="18357,33569">norepinephrine</z:chebi> metabolites <z:chebi fb="0" ids="20106">vanillylmandelic acid</z:chebi> (VMA) and <z:chebi fb="1" ids="17650">cortisol</z:chebi> were determined and transcranial Doppler ultrasonography was performed on day 1 of hospital stay and repeated after 21-day psychiatric medicamentous treatment </plain></SENT>
<SENT sid="4" pm="."><plain>On initial testing, increased level of 24-h VMA, decreased <z:chebi fb="1" ids="17650">cortisol</z:chebi> level and elevated mean blood flow velocity (MBFV) in the circle of Willis vessels were recorded in 25 (50.00%) patients </plain></SENT>
<SENT sid="5" pm="."><plain>Repeat findings obtained after 21-day psychopharmaceutical therapy showed increased 24-h VMA, decreased <z:chebi fb="1" ids="17650">cortisol</z:chebi> and elevated MBFV in the circle of Willis vessels in seven (14.00%) patients (initial vs. repeat testing, P = 0.0002) </plain></SENT>
<SENT sid="6" pm="."><plain>Such parameters were not recorded in any of the control subjects (initial <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTSD</z:e> patient testing vs. control group, P = 0.0000) </plain></SENT>
<SENT sid="7" pm="."><plain>Study results pointed to a significant correlation between increased <z:chebi fb="2" ids="33567">catecholamine</z:chebi> levels, decreased <z:chebi fb="1" ids="17650">cortisol</z:chebi> level and elevated MBFV in the circle of Willis vessels caused by <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Psychiatric medicamentous therapy administered for three weeks significantly reduced the proportion of patients with concurrently altered cerebral hemodynamics, increased levels of <z:chebi fb="2" ids="33567">catecholamine</z:chebi> metabolites and decreased level of <z:chebi fb="1" ids="17650">cortisol</z:chebi> </plain></SENT>
</text></document>